Author: Dr. David Lowemann

Lilly to Doctors: Stop Selling Copycat Weight-Loss Drugs

Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days demanding they stop the promotion of copycat weight-loss drugs as the supply of its brand-name medicines improves, Bloomberg News reported Wednesday. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future […]

Published on August 14, 2024

Scientists Predict Diseases by Analyzing Tongue

A computer algorithm developed by Iraqi and Australian researchers can diagnose diabetes, stroke, anemia, COVID-19, and a wide range of vascular and gastrointestinal issues with remarkable accuracy by observing the color of your tongue. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future […]

Published on August 14, 2024

Bout of Shingles May Raise Odds for Cognitive Decline

Older Americans already dread shingles, and they may now have one more reason to do so: A painful episode could raise their odds for cognitive decline. A new study found a 20% higher risk that an older person would experience “subjective cognitive decline” if they’d gone… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on August 14, 2024